Investigation of Metabolic Bone Diseases, Metabolic Bone Diseases, Integrative Physiology of the Skeleton
Role of Vitamin D Deficiency in Chronic Kidney Disease
Stuart Sprague, D.O., Northwestern University, Evanston, Illinois, USA
Paradoxical Effects of Active Vitamin D Analogue Agents in CKD/End Stage Kidney Disease
L. Darryl Quarles, M.D., University of Kansas Medical Center, Kansas City, Kansas, USA
Effects of Vitamin D and Analogues on Cardiovascular Events and Life Expectancy in Patients with CRF
Sharon M. Moe, M.D., Indiana University School of Medicine, Indianapolis, Indiana, USA
Management of Renal Osteodystrophy in Childhood
Mary B. Leonard, M.D., MSCE, Children’s Hospital of Philadelphia, Philadelphia,
Supported by educational grants from Eli Lilly and Company, Merck & Co., Inc., NPS Pharmaceuticals, The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis, US) and Immunodiagnostic Systems.
Funding for this conference was made possible (in part) by Grant AR055036 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases and the Office of Dietary Supplements. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Length: 85 minutes